日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cancer as a Channelopathy-Appreciation of Complimentary Pathways Provides a Different Perspective for Developing Treatments

癌症作为一种离子通道病——对互补通路的认识为开发治疗方法提供了不同的视角

Gould, Harry J 3rd; Paul, Dennis

Targeted Osmotic Lysis: A Novel Approach to Targeted Cancer Therapies

靶向渗透溶解:一种新型的靶向癌症治疗方法

Gould, Harry J 3rd; Paul, Dennis

The Role of Targeted Osmotic Lysis in the Treatment of Advanced Carcinoma in Companion Animals: A Case Series

靶向渗透溶解疗法在伴侣动物晚期癌治疗中的作用:病例系列研究

Gould, Harry J 3rd; Edenfield, Samantha; Miller, Paige R; Sherman, Kelly Jean; Melius, Brian; Whitney, Alissa; Hunter, Robert P; Del Piero, Fabio; Tracey, Dennis; Paul, Dennis

Emergency Use of Targeted Osmotic Lysis for the Treatment of a Patient with Aggressive Late-Stage Squamous Cell Carcinoma of the Cervix

紧急应用靶向渗透溶解术治疗侵袭性晚期宫颈鳞状细胞癌患者

Gould, Harry J 3rd; Miller, Paige R; Edenfield, Samantha; Sherman, Kelly Jean; Brady, Chad K; Paul, Dennis

Why Leading Consumer Product Companies Develop Proactive Chemical Management Strategies

为什么领先的消费品公司要制定积极主动的化学品管理策略

Scruggs, Caroline E; Van Buren, Harry J 3rd

Factors associated with grade 3 or 4 treatment-related toxicity in women with advanced or recurrent cervical cancer: an exploratory analysis of NRG Oncology/Gynecologic Oncology Group trials 179 and 204

晚期或复发性宫颈癌女性患者发生 3 级或 4 级治疗相关毒性的因素:NRG 肿瘤/妇科肿瘤组 179 和 204 号试验的探索性分析

Chase, Dana M; Kauderer, James; Wenzel, Lari; Ramondetta, Lois; Cella, David; Long, Harry J 3rd; Monk, Bradley J

Critical appraisal of extended-release hydrocodone for chronic pain: patient considerations

对缓释氢可酮治疗慢性疼痛的批判性评价:患者考量

Gould, Harry J 3rd; Paul, Dennis